Barclays analyst Peter Lawson lowered the firm’s price target on Geron (GERN) to $4 from $9 and keeps an Overweight rating on the shares post the Q4 report. The firm updated its model to reflect the slowdown seen over the past two months, with a potential revenue turnaround in 2025. It likes the stock’s risk/reward at current levels.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GERN:
- Geron Corporation Reports Strong 2024 Financial Results
- Geron downgraded to Neutral from Buy at B. Riley
- Geron Inc.: Strategic Market Position and Rytelo’s Potential Justify Buy Rating
- Geron’s Strategic Focus on Regional Engagement and Early Line Uptake to Drive Growth
- H.C. Wainwright downgrades Geron on strategy shift, data delay